top of page

GSK Salbutamol Programme
Project Description:
M2 Build is an Oral Solid Dose facility (OSD), producing tablets and capsules for the GSK brand.
The project was a blend of modular design (DFMA) and traditional ‘stick built’ construction.
Key Challenges:
Providing a GMP environment
DFMA Modular Design
Should you wish to know more about our role on Science, Research and Healthcare projects, please contact hello@iM2ltd.com
iM2 Role: Principal Designer
Project Team:
Client: GSK
Architect: Simons Design Ltd
Engineer: Shepherd Gilmore
MEP: NG Bailey
PC: GSK
Start Date: July 2020
Completion: January 2023
Value: (£) Confidential



bottom of page